GNS-3545
/ Oscotec
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 07, 2025
A Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GNS-3545 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=72 | Recruiting | Sponsor: Genosco Inc.
New P1 trial • Idiopathic Pulmonary Fibrosis • Immunology • Pulmonary Disease • Respiratory Diseases
1 to 1
Of
1
Go to page
1